{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:31:36Z","timestamp":1787869896746,"version":"build-2784847793"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K08600"],"award-info":[{"award-number":["JP23K08600"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K06758"],"award-info":[{"award-number":["23K06758"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-025-01308-6","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:59:18Z","timestamp":1759996758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Establishment of human histiocytic sarcoma organoids dependent on the SHH\/YAP pathway"],"prefix":"10.1007","volume":"38","author":[{"given":"Yusuke","family":"Yoshimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Sasagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Nagamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Kukita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironari","family":"Tamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Kakunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinari","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Terakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Imura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3073-0595","authenticated-orcid":false,"given":"Toru","family":"Wakamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"1308_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00428-017-2176-1","volume":"471","author":"F Facchetti","year":"2017","unstructured":"Facchetti F, Pileri SA, Lorenzi L, Tabanelli V, Rimsza L, Pittaluga S, et al. Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases. Virchows Archiv. 2017;471:467\u201389.","journal-title":"Virchows Archiv."},{"issue":"4","key":"1308_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1177\/107327481402100405","volume":"21","author":"S Dalia","year":"2014","unstructured":"Dalia S, Shao H, Sagatys E, Cualing H, Sokol L. Dendritic cell and histiocytic neoplasms: biology, diagnosis, and treatment. Cancer Control. 2014;21(4):290\u2013300.","journal-title":"Cancer Control"},{"issue":"4","key":"1308_CR3","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.3390\/cancers6042275","volume":"6","author":"S Dalia","year":"2014","unstructured":"Dalia S, Jaglal M, Chervenick P, Cualing H, Sokol L. Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years. Cancers. 2014;6(4):2275\u201395.","journal-title":"Cancers"},{"issue":"3","key":"1308_CR4","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.path.2019.03.013","volume":"12","author":"Z Pan","year":"2019","unstructured":"Pan Z, Xu ML. Histiocytic and dendritic cell neoplasms. Surg Pathol Clin. 2019;12(3):805\u201329.","journal-title":"Surg Pathol Clin"},{"issue":"5","key":"1308_CR5","doi-asserted-by":"publisher","first-page":"650","DOI":"10.5858\/arpa.2018-0349-RS","volume":"144","author":"YP Hung","year":"2020","unstructured":"Hung YP, Qian X. Histiocytic sarcoma. Arch Pathol Lab Med. 2020;144(5):650\u20134.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"1308_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3960\/jslrt.53.1","volume":"53","author":"E Takahashi","year":"2013","unstructured":"Takahashi E, Nakamura S. Histiocytic sarcoma: an updated literature review based on the 2008 WHO classification. J Clin Exp Hematop. 2013;53(1):1\u20138.","journal-title":"J Clin Exp Hematop"},{"issue":"5","key":"1308_CR7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/modpathol.3800346","volume":"18","author":"JA Vos","year":"2005","unstructured":"Vos JA, Abbondanzo SL, Barekman CL, Andriko JW, Miettinen M, Aguilera NS. Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol. 2005;18(5):693\u2013704.","journal-title":"Mod Pathol"},{"issue":"9","key":"1308_CR8","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/01.pas.0000131541.95394.23","volume":"28","author":"JL Hornick","year":"2004","unstructured":"Hornick JL, Jaffe ES, Fletcher CD. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol. 2004;28(9):1133\u201344.","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"1308_CR9","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.5858\/arpa.2018-0220-RA","volume":"142","author":"SL Skala","year":"2018","unstructured":"Skala SL, Lucas DR, Dewar R. Histiocytic sarcoma: review, discussion of transformation from B-cell lymphoma, and differential diagnosis. Arch Pathol Lab Med. 2018;142(11):1322\u20139.","journal-title":"Arch Pathol Lab Med"},{"key":"1308_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12185-010-0603-z","volume":"92","author":"M Mori","year":"2010","unstructured":"Mori M, Matsushita A, Takiuchi Y, Arima H, Nagano S, Shimoji S, et al. Histiocytic sarcoma and underlying chronic myelomonocytic leukemia: a proposal for the developmental classification of histiocytic sarcoma. Int J Hematol. 2010;92:168\u201373.","journal-title":"Int J Hematol."},{"issue":"4","key":"1308_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S1470-2045(04)01428-7","volume":"5","author":"AL Feldman","year":"2004","unstructured":"Feldman AL, Minniti C, Santi M, Downing JR, Raffeld M, Jaffe ES. Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin. Lancet Oncol. 2004;5(4):248\u201350.","journal-title":"Lancet Oncol"},{"issue":"11","key":"1308_CR12","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/modpathol.2011.102","volume":"24","author":"H Shao","year":"2011","unstructured":"Shao H, Xi L, Raffeld M, Feldman AL, Ketterling RP, Knudson R, et al. Clonally related histiocytic\/dendritic cell sarcoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma: a study of seven cases. Modern Pathol. 2011;24(11):1421\u201332.","journal-title":"Modern Pathol"},{"issue":"2","key":"1308_CR13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41379-020-00673-x","volume":"34","author":"C Egan","year":"2021","unstructured":"Egan C, Lack J, Skarshaug S, Pham TA, Abdullaev Z, Xi L, et al. The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy. Modern Pathol. 2021;34(2):336\u201347.","journal-title":"Modern Pathol"},{"key":"1308_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.humpath.2016.04.004","volume":"55","author":"S Fernandez-Pol","year":"2016","unstructured":"Fernandez-Pol S, Bangs CD, Cherry A, Arber DA, Gratzinger D. Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma. Hum Pathol. 2016;55:39\u201343.","journal-title":"Hum Pathol"},{"issue":"2","key":"1308_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/his.12416","volume":"65","author":"H Go","year":"2014","unstructured":"Go H, Jeon YK, Huh J, Choi SJ, Choi YD, Cha HJ, et al. Frequent detection of BRAFV 600E mutations in histiocytic and dendritic cell neoplasms. Histopathology. 2014;65(2):261\u201372.","journal-title":"Histopathology."},{"issue":"16","key":"1308_CR16","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1212\/WNL.0000000000000880","volume":"83","author":"A Idbaih","year":"2014","unstructured":"Idbaih A, Mokhtari K, Emile JF, Galanaud D, Belaid H, de Bernard S, et al. Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib. Neurology. 2014;83(16):1478\u201380.","journal-title":"Neurology."},{"issue":"20","key":"1308_CR17","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1056\/NEJMc1511490","volume":"378","author":"MM Gounder","year":"2018","unstructured":"Gounder MM, Solit DB, Tap WD. Trametinib in histiocytic sarcoma with an activating MAP2K1 (MEK1) mutation. N Engl J Med. 2018;378(20):1945\u20137.","journal-title":"N Engl J Med"},{"issue":"6","key":"1308_CR18","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41379-018-0200-x","volume":"32","author":"V Shanmugam","year":"2019","unstructured":"Shanmugam V, Griffin GK, Jacobsen ED, Fletcher CD, Sholl LM, Hornick JL. Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma. Mod Pathol. 2019;32(6):830\u201343.","journal-title":"Mod Pathol"},{"key":"1308_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12185-018-2553-9","volume":"109","author":"T Kumamoto","year":"2019","unstructured":"Kumamoto T, Aoki Y, Sonoda T, Yamanishi M, Arakawa A, Sugiyama M, et al. A case of recurrent histiocytic sarcoma with MAP2K1 pathogenic variant treated with the MEK inhibitor trametinib. Int J Hematol. 2019;109:228\u201332.","journal-title":"Int J Hematol"},{"issue":"4","key":"1308_CR20","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3324\/haematol.2019.230375","volume":"105","author":"C Egan","year":"2019","unstructured":"Egan C, Nicolae A, Lack J, Chung HJ, Skarshaug S, Pham TA, et al. Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups. Haematologica. 2019;105(4):951.","journal-title":"Haematologica."},{"issue":"6444","key":"1308_CR21","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1126\/science.aaw6985","volume":"364","author":"D Tuveson","year":"2019","unstructured":"Tuveson D, Clevers H. Cancer modeling meets human organoid technology. Science. 2019;364(6444):952\u20135.","journal-title":"Science"},{"key":"1308_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-018-0662-9","volume":"11","author":"H Xu","year":"2018","unstructured":"Xu H, Lyu X, Yi M, Zhao W, Song Y, Wu K. Organoid technology and applications in cancer research. J Hematol Oncol. 2018;11:1\u201315.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"1308_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00109-020-01990-z","volume":"99","author":"K Kretzschmar","year":"2021","unstructured":"Kretzschmar K. Cancer research using organoid technology. J Mol Med. 2021;99(4):501\u201315.","journal-title":"J Mol Med"},{"key":"1308_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.gde.2013.11.012","volume":"24","author":"N Sachs","year":"2014","unstructured":"Sachs N, Clevers H. Organoid cultures for the analysis of cancer phenotypes. Curr Opin Genet Dev. 2014;24:68\u201373.","journal-title":"Curr Opin Genet Dev"},{"issue":"7","key":"1308_CR25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","volume":"18","author":"J Drost","year":"2018","unstructured":"Drost J, Clevers H. Organoids in cancer research. Nat Rev Cancer. 2018;18(7):407\u201318.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1308_CR26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","volume":"159","author":"D Gao","year":"2014","unstructured":"Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159(1):176\u201387.","journal-title":"Cell."},{"key":"1308_CR27","doi-asserted-by":"publisher","first-page":"893592","DOI":"10.3389\/fonc.2022.893592","volume":"12","author":"T Wakamatsu","year":"2022","unstructured":"Wakamatsu T, Ogawa H, Yoshida K, Matsuoka Y, Shizuma K, Imura Y, et al. Establishment of organoids from human epithelioid sarcoma with the air-liquid interface organoid cultures. Front Oncol. 2022;12:893592.","journal-title":"Front Oncol"},{"key":"1308_CR28","doi-asserted-by":"publisher","first-page":"100486","DOI":"10.1016\/j.jbo.2023.100486","volume":"41","author":"R Suzuki","year":"2023","unstructured":"Suzuki R, Wakamatsu T, Yoshida K, Matsuoka Y, Takami H, Nakai S, et al. Genetic characterization of a novel organoid from human malignant giant-cell tumor. J Bone Oncol. 2023;41:100486.","journal-title":"J Bone Oncol"},{"issue":"12","key":"1308_CR29","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1292\/jvms.68.1343","volume":"68","author":"D Azakami","year":"2006","unstructured":"Azakami D, Bonkobara M, Washizu T, Iida A, Kondo M, Kato R, et al. Establishment and biological characterization of canine histiocytic sarcoma cell lines. J Veterin Med Sci. 2006;68(12):1343\u20136.","journal-title":"J Veterin Med Sci"},{"issue":"11","key":"1308_CR30","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1158\/1535-7163.MCT-17-1273","volume":"17","author":"M Takada","year":"2018","unstructured":"Takada M, Hix JM, Corner S, Schall PZ, Kiupel M, Yuzbasiyan-Gurkan V. Targeting MEK in a translational model of histiocytic sarcoma. Mol Cancer Ther. 2018;17(11):2439\u201350.","journal-title":"Mol Cancer Ther"},{"key":"1308_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4132-0","volume":"18","author":"M Takada","year":"2018","unstructured":"Takada M, Parys M, Gregory-Bryson E, Vilar Saavedra P, Kiupel M, Yuzbasiyan-Gurkan V. A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies. BMC Cancer. 2018;18:1\u201313.","journal-title":"BMC Cancer"},{"issue":"3","key":"1308_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/0300985817690211","volume":"54","author":"A Thongtharb","year":"2017","unstructured":"Thongtharb A, Uchida K, Chambers JK, Nakayama H. Variations in histiocytic differentiation of cell lines from canine cerebral and articular histiocytic sarcomas. Vet Pathol. 2017;54(3):395\u2013404.","journal-title":"Vet Pathol"},{"issue":"2","key":"1308_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1354\/vp.44-2-151","volume":"44","author":"J Yamate","year":"2007","unstructured":"Yamate J, Fumimoto S, Kuwamura M, Kotani T, Lamarre J. Characterization of a rat subcutaneous malignant fibrous histiocytoma and its tumor lines, with reference to histiocytic features. Vet Pathol. 2007;44(2):151\u201360.","journal-title":"Vet Pathol"},{"issue":"2\u20133","key":"1308_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1053\/jcpa.2000.0452","volume":"124","author":"J Yamate","year":"2001","unstructured":"Yamate J, Maeda M, Tsukamoto Y, Benn SJ, Laithwaite JE, Allan A, et al. Macrophage-like cell line (HS-P) from a rat histiocytic sarcoma. J Comp Pathol. 2001;124(2\u20133):183\u201391.","journal-title":"J Comp Pathol"},{"issue":"2","key":"1308_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.113","volume":"3","author":"S Sasagawa","year":"2024","unstructured":"Sasagawa S, Kumai J, Wakamatsu T, Yui Y. Improvement of histone deacetylase inhibitor efficacy by SN38 through TWIST1 suppression in synovial sarcoma. Cancer Innov. 2024;3(2):e113.","journal-title":"Cancer Innov"},{"key":"1308_CR36","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12859-018-2486-6","volume":"19","author":"SX Ge","year":"2018","unstructured":"Ge SX, Son EW, Yao R. iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data. BMC Bioinformatics. 2018;19:534. https:\/\/doi.org\/10.1186\/s12859-018-2486-6.","journal-title":"BMC Bioinformatics"},{"key":"1308_CR37","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1093\/bioinformatics\/btz854","volume":"36","author":"C Prieto","year":"2020","unstructured":"Prieto C, Barrios D. RaNA-seq: interactive RNA-seq analysis from FASTQ files for functional analysis. Bioinformatics. 2020;36:1955\u20136. https:\/\/doi.org\/10.1093\/bioinformatics\/btz854.","journal-title":"Bioinformatics"},{"issue":"23","key":"1308_CR38","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1101\/gad.1824509","volume":"23","author":"A Fernandez-L","year":"2009","unstructured":"Fernandez-L A, Northcott PA, Dalton J, Fraga C, Ellison D, Angers S, et al. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Develop. 2009;23(23):2729\u201341.","journal-title":"Genes Develop"},{"issue":"15","key":"1308_CR39","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.yexcr.2012.05.005","volume":"318","author":"YT Lin","year":"2012","unstructured":"Lin YT, Ding JY, Li MY, Yeh TS, Wang TW, Yu JY. YAP regulates neuronal differentiation through Sonic hedgehog signaling pathway. Exp Cell Res. 2012;318(15):1877\u201388.","journal-title":"Exp Cell Res"},{"issue":"1","key":"1308_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.devcel.2017.08.019","volume":"43","author":"JL Cotton","year":"2017","unstructured":"Cotton JL, Li Q, Ma L, Park JS, Wang J, Ou J, et al. YAP\/TAZ and hedgehog coordinate growth and patterning in gastrointestinal mesenchyme. Develop Cell. 2017;43(1):35\u201347.","journal-title":"Develop Cell."},{"issue":"8","key":"1308_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183178","volume":"12","author":"B Akladios","year":"2017","unstructured":"Akladios B, Mendoza Reinoso V, Cain JE, Wang T, Lambie DL, Watkins DN, et al. Positive regulatory interactions between YAP and Hedgehog signalling in skin homeostasis and BCC development in mouse skin in vivo. PLoS ONE. 2017;12(8):e0183178.","journal-title":"PLoS ONE"},{"issue":"7","key":"1308_CR42","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3390\/genes10070505","volume":"10","author":"M Takada","year":"2019","unstructured":"Takada M, Smyth LA, Thaiwong T, Richter M, Corner SM, Schall PZ, et al. Activating mutations in PTPN11 and KRAS in canine histiocytic sarcomas. Genes. 2019;10(7):505.","journal-title":"Genes."},{"issue":"1","key":"1308_CR43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2353\/ajpath.2006.050001","volume":"168","author":"TD Tiet","year":"2006","unstructured":"Tiet TD, Hopyan S, Nadesan P, Gokgoz N, Poon R, Lin AC, et al. Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation. Am J Pathol. 2006;168(1):321\u201330.","journal-title":"Am J Pathol"},{"key":"1308_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-015-0489-8","volume":"15","author":"A Hanna","year":"2016","unstructured":"Hanna A, Shevde LA. Hedgehog signaling: modulation of cancer properties and tumor microenvironment. Mol Cancer. 2016;15:1\u201314.","journal-title":"Mol Cancer"},{"issue":"7","key":"1308_CR45","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1038\/s41418-021-00749-4","volume":"28","author":"W Wang","year":"2021","unstructured":"Wang W, Yan T, Guo W, Niu J, Zhao Z, Sun K, et al. Constitutive GLI1 expression in chondrosarcoma is regulated by major vault protein via mTOR\/S6K1 signaling cascade. Cell Death Different. 2021;28(7):2221\u201337.","journal-title":"Cell Death Different"},{"issue":"11","key":"1308_CR46","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.3390\/cancers12113438","volume":"12","author":"M Mullard","year":"2020","unstructured":"Mullard M, Cad\u00e9 M, Morice S, Dupuy M, Danieau G, Amiaud J, et al. Sonic hedgehog signature in pediatric primary bone tumors: effects of the GLI antagonist GANT61 on ewing\u2019s sarcoma tumor growth. Cancers. 2020;12(11):3438.","journal-title":"Cancers."}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01308-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-025-01308-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01308-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:10:53Z","timestamp":1760001053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-025-01308-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["1308"],"URL":"https:\/\/doi.org\/10.1007\/s13577-025-01308-6","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that this study was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The use of clinical materials for this study was approved by the Ethics Committee of Osaka International Cancer Institute (approval number: 1710059174-12), and all procedures were conducted in accordance with institutional and national ethical guidelines. Written informed consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent to participate"}}],"article-number":"175"}}